The Experts below are selected from a list of 339 Experts worldwide ranked by ideXlab platform
Christopher B Zachary - One of the best experts on this subject based on the ideXlab platform.
-
fractionated ablative carbon dioxide laser for the treatment of Rhinophyma
Lasers in Surgery and Medicine, 2014Co-Authors: Kathryn Serowka, Nazanin Saedi, Jeffrey S Dover, Christopher B ZacharyAbstract:Background Rhinophyma is a progressive and disfiguring proliferative disorder of the nose, which is related to chronic rosacea. Many different treatment modalities have been utilized both alone and in combination including: loop cautery, CO2 laser, argon laser, dermabrasion, cryotherapy, radiotherapy, full-thickness excision, skin graft, flap reconstruction, and cold scalpel. CO2 resurfacing has been considered first line therapy but is often associated with a shiny, scarred appearance, with patulous pores, and with loss of pigmentation. We report a technique using aggressive parameters with the fractionated ablative CO2 laser, resulting in improvement of appearance with very few complications. Materials and Methods Five patients who presented with Rhinophyma of varying degrees were treated with a series of fractional ablative CO2 laser treatments (Fraxel re:Pair, Solta Medical, Hayward, CA). These patients were treated with settings of up to 70 mJ, 70% density and 16–18 passes. All patients received HSV prophylaxis using either acyclovir 400 mg TID or valacyclovir 500 mg BID. Patients were rendered anesthetic by 1% lidocaine and epinephrine regional perinasal nerve block. Results All of the patients tolerated the procedure well with reepithelialization at days 4–7 and self-limited edema and erythema. Patients with relatively early to moderate signs of Rhinophyma proved optimal candidates for this treatment. There were no adverse events. Patients and physicians noted significant improvement and reduction in the Rhinophyma without the typical scarring noted with most other treatments. Conclusion Rhinophyma treated with fractionated ablative CO2 laser using relatively aggressive parameters achieved good cosmetic outcomes in this group of early to moderate cases of Rhinophyma, while still retaining the benefits of a fractionated treatment such as faster healing times and fewer adverse events. Lasers Surg. Med. 46:8–12, 2014. © 2013 Wiley Periodicals, Inc.
Kathryn Serowka - One of the best experts on this subject based on the ideXlab platform.
-
fractionated ablative carbon dioxide laser for the treatment of Rhinophyma
Lasers in Surgery and Medicine, 2014Co-Authors: Kathryn Serowka, Nazanin Saedi, Jeffrey S Dover, Christopher B ZacharyAbstract:Background Rhinophyma is a progressive and disfiguring proliferative disorder of the nose, which is related to chronic rosacea. Many different treatment modalities have been utilized both alone and in combination including: loop cautery, CO2 laser, argon laser, dermabrasion, cryotherapy, radiotherapy, full-thickness excision, skin graft, flap reconstruction, and cold scalpel. CO2 resurfacing has been considered first line therapy but is often associated with a shiny, scarred appearance, with patulous pores, and with loss of pigmentation. We report a technique using aggressive parameters with the fractionated ablative CO2 laser, resulting in improvement of appearance with very few complications. Materials and Methods Five patients who presented with Rhinophyma of varying degrees were treated with a series of fractional ablative CO2 laser treatments (Fraxel re:Pair, Solta Medical, Hayward, CA). These patients were treated with settings of up to 70 mJ, 70% density and 16–18 passes. All patients received HSV prophylaxis using either acyclovir 400 mg TID or valacyclovir 500 mg BID. Patients were rendered anesthetic by 1% lidocaine and epinephrine regional perinasal nerve block. Results All of the patients tolerated the procedure well with reepithelialization at days 4–7 and self-limited edema and erythema. Patients with relatively early to moderate signs of Rhinophyma proved optimal candidates for this treatment. There were no adverse events. Patients and physicians noted significant improvement and reduction in the Rhinophyma without the typical scarring noted with most other treatments. Conclusion Rhinophyma treated with fractionated ablative CO2 laser using relatively aggressive parameters achieved good cosmetic outcomes in this group of early to moderate cases of Rhinophyma, while still retaining the benefits of a fractionated treatment such as faster healing times and fewer adverse events. Lasers Surg. Med. 46:8–12, 2014. © 2013 Wiley Periodicals, Inc.
P J August - One of the best experts on this subject based on the ideXlab platform.
-
carbon dioxide laser treatment of Rhinophyma a review of 124 patients
British Journal of Dermatology, 2009Co-Authors: Vishal Madan, J E Ferguson, P J AugustAbstract:Background Rhinophyma is a progressive, localized or generalized nasal deformity resulting from hypertrophy of sebaceous and connective tissue. The CO(2) laser has been used for treatment of Rhinophyma, but the long-term efficacy of the treatment is unknown. Objectives To review the outcome of 124 patients with Rhinophyma treated with the CO(2) laser between 1996 and 2008 in our centre. Patients and methods Exuberant sebaceous tissue was ablated using the Sharplan 40C CO(2) laser (Sharplan Lasers UK Ltd, London, U.K.) under local anaesthesia. The technique varied with the severity of Rhinophyma; the laser was used in a continuous mode to debulk the larger Rhinophymas, and in a resurfacing mode (Silk Touch scanner; Sharplan, 4-7-mm spot at 20-40 W) or continuous mode (10-20 W using a defocused 2-3-mm beam) to reshape the nasal contours. Outcomes were determined by case notes, clinical review and questionnaire. Results Laser treatment was completed in a single session in 115 of 124 patients. All patients were reviewed 3 months post-treatment. Results were classified as good to excellent in 118 and poor in six patients. All patients were sent a satisfaction questionnaire in 2008 and 52 patients replied. Patients reported high levels of satisfaction following treatment. The post-treatment response at 3-month review was maintained long term. The main complications were pain associated with injection of local anaesthetic, scarring and hypopigmentation (four patients) and open pores (two patients). Conclusions The CO(2) laser is an effective and durable treatment for Rhinophyma. Treatment carries a low risk of side-effects and is associated with high patient acceptability and satisfaction.
J P Callen - One of the best experts on this subject based on the ideXlab platform.
-
Rhinophyma like swelling of the nose due to squamous cell carcinoma of the lung metastatic to the nasal tip a case report
European Journal of Dermatology, 1995Co-Authors: N H French, T S Williams, J P CallenAbstract:A patient with squamous cell carcinoma of the lung metastatic to the nasal tip which resembled a Rhinophyma is reported. The clinical and histopathologic features of this metastatic skin lesion are described. This case illustrates the need for biopsy of unexplained skin lesions
Jeffrey S Dover - One of the best experts on this subject based on the ideXlab platform.
-
fractionated ablative carbon dioxide laser for the treatment of Rhinophyma
Lasers in Surgery and Medicine, 2014Co-Authors: Kathryn Serowka, Nazanin Saedi, Jeffrey S Dover, Christopher B ZacharyAbstract:Background Rhinophyma is a progressive and disfiguring proliferative disorder of the nose, which is related to chronic rosacea. Many different treatment modalities have been utilized both alone and in combination including: loop cautery, CO2 laser, argon laser, dermabrasion, cryotherapy, radiotherapy, full-thickness excision, skin graft, flap reconstruction, and cold scalpel. CO2 resurfacing has been considered first line therapy but is often associated with a shiny, scarred appearance, with patulous pores, and with loss of pigmentation. We report a technique using aggressive parameters with the fractionated ablative CO2 laser, resulting in improvement of appearance with very few complications. Materials and Methods Five patients who presented with Rhinophyma of varying degrees were treated with a series of fractional ablative CO2 laser treatments (Fraxel re:Pair, Solta Medical, Hayward, CA). These patients were treated with settings of up to 70 mJ, 70% density and 16–18 passes. All patients received HSV prophylaxis using either acyclovir 400 mg TID or valacyclovir 500 mg BID. Patients were rendered anesthetic by 1% lidocaine and epinephrine regional perinasal nerve block. Results All of the patients tolerated the procedure well with reepithelialization at days 4–7 and self-limited edema and erythema. Patients with relatively early to moderate signs of Rhinophyma proved optimal candidates for this treatment. There were no adverse events. Patients and physicians noted significant improvement and reduction in the Rhinophyma without the typical scarring noted with most other treatments. Conclusion Rhinophyma treated with fractionated ablative CO2 laser using relatively aggressive parameters achieved good cosmetic outcomes in this group of early to moderate cases of Rhinophyma, while still retaining the benefits of a fractionated treatment such as faster healing times and fewer adverse events. Lasers Surg. Med. 46:8–12, 2014. © 2013 Wiley Periodicals, Inc.